Josefina Romaguera

Prof. Josefina Romaguera

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2021 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
PDF file
EBErika Benabe
Erika Benabe
YFYesenia Fuentes
Yesenia Fuentes
GRGabriela Roldan
Gabriela Roldan
MRMariluz Ramos
Mariluz Ramos
MPManuel Pastrana
Manuel Pastrana
JRJosefina Romaguera
Josefina Romaguera

15 January 2020 in Metabolites
Verified
Journal Article
Open access
PDF file
NCNataliya Chorna
Nataliya Chorna
JRJosefina Romaguera
Josefina Romaguera
FGFilipa Godoy-Vitorino
Filipa Godoy-Vitorino
In this study, we evaluate the association between vaginal and cervical human papillomavirus infections high-risk types (HPV+H), negative controls (HPV−), the bacterial biota, and urinary metabolites via integration of metagenomics, metabolomics, and bioinformatics analysis. We recently proposed that testing urine as a biofluid could be a non-invasive method for the detection of cervical HPV+H infections by evaluating the association between cervical HPV types and a total of 24 urinary metabolites identified in the samples. As a follow-up study, we expanded the analysis by pairing the urine metabolome data with vaginal and cervical microbiota in selected samples from 19 Puerto Rican women diagnosed with HPV+H infections and HPV− controls, using a novel comprehensive framework, Model-based Integration of Metabolite Observations and Species Abundances 2 (MIMOSA2). This approach enabled us to estimate the functional activities of the cervicovaginal microbiome associated with HPV+H infections. Our results suggest that HPV+H infections could induce changes in physicochemical properties of the genital tract through which niche partitioning may occur. As a result, Lactobacillus sp. enrichment coincided with the depletion of L. iners and Shuttleworthia, which dominate under normal physiological conditions. Changes in the diversity of microbial species in HPV+H groups influence the capacity of new community members to produce or consume metabolites. In particular, the functionalities of four metabolic enzymes were predicted to be associated with the microbiota, including acylphosphatase, prolyl aminopeptidase, prolyl-tRNA synthetase, and threonyl-tRNA synthetase. Such metabolic changes may influence systemic health effects in women at risk of developing cervical cancer. Overall, even assuming the limitation of the power due to the small sample number, our study adds to current knowledge by suggesting how microbial taxonomic and metabolic shifts induced by HPV infections may influence the maintenance of microbial homeostasis and indicate that HPV+H infections may alter the ecological balance of the cervicovaginal microbiota, resulting in higher bacterial diversity.

1 March 2010 in Menopause
Verified
Journal Article
Closed access
JRJosefina Romaguera
Josefina Romaguera
AOAna P. Ortiz
Ana P. Ortiz
FRFernando J. Roca
Fernando J. Roca
GCGiancarlo Colón
Giancarlo Colón
ESErick Suárez
Erick Suárez
The aim of this study was to determine the association between metabolic syndrome (MetS) and demographic, health, and lifestyle characteristics in a sample of women living in Puerto Rico. The study group consisted of 214 women aged 36 to 82 years, residing in the metropolitan area of San Juan, Puerto Rico. Demographic, reproductive, lifestyle, and metabolic variables were assessed through an annual questionnaire and blood chemistries. MetS was defined according to the criteria set by the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults/Adult Treatment Panel III (NCEP/ATP III) and the International Diabetes Federation (IDF). The overall prevalence of MetS was 24% according to NCEP/ATP III criteria and 33% according to IDF criteria. When using the IDF criteria, 37% of participants older than 51 years have MetS, in contrast to 28% when using the NCEP/ATP III criteria. Obese women have an increased probability of MetS when adjusting for age, education level, menopause status, and/or alcohol use (IDF criteria: estimated odds ratio [OR], 2.68; 95% CI, 1.44-4.97; NCEP/ATP III criteria: estimated OR, 3.42; 95% CI, 1.71-6.84). A higher education level (estimated OR, 0.45; 95% CI, 0.23-0.92 [IDF criteria]) and alcohol consumption (estimated OR, 0.48; 95% CI, 0.23-0.99 [NCEP/ATP III criteria]) seem to provide a protective effect, when adjusting for confounders. Our study confirms obesity as an important risk factor associated with MetS in this sample of women in Puerto Rico. Alcohol consumption and a higher education level seem to decrease the prevalence of MetS. In view of this, patient counseling regarding weight reduction and lifestyle modification should be emphasized in the primary prevention and management of MetS. Additional studies are warranted to further characterize the effect of menopause status on MetS.

1 June 2010 in Metabolic Syndrome and Related Disorders
Verified
Journal Article
Open access
AOAna Patricia Ortiz
Ana Patricia Ortiz
ESErick Suárez
Erick Suárez
GBGiovanna Beauchamp
Giovanna Beauchamp
JRJosefina Romaguera
Josefina Romaguera
MSMarievelisse Soto-Salgado
Marievelisse Soto-Salgado
CPCynthia M. Pérez
Cynthia M. Pérez
Background: The metabolic syndrome is an interaction of risk factors that may lead to cardiovascular disease and type 2 diabetes. Methods: Given the need for data in Puerto Rico, this cross-sectional study aimed to determine the association between demographic, lifestyles, and reproductive characteristics and the metabolic syndrome among a sample of women (N = 564) in the San Juan Metropolitan Area. The metabolic syndrome was defined based on the revised National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria. Results: In multivariate logistic regression models, women aged 40–59 and 60–79 years were 3.03 [95% confidence interval (CI), 1.70, 5.40] and 7.05 (95% CI, 3.69, 13.49) times more likely, respectively, to have the metabolic syndrome as compared to those aged 21–39 years. A dose–response relationship was also observed between body mass index (BMI) and metabolic syndrome. Physical activity reduced the odds for metabolic syndrome [prevalence odds ratios (POR) = 0.64; 95% CI, 0.41, 1.01]; however, this association was marginally significant (P = 0.05). Among reproductive characteristics, only women who had a history of gestational diabetes (GDM) were 2.14 (95% CI, 1.02, 4.51) times more likely to have metabolic syndrome. Conclusions: Consistent with previous studies, increased age and BMI, physical inactivity, and GDM are associated with the metabolic syndrome in this population. This information is relevant for the development of preventive interventions for the metabolic syndrome.

14 July 2015 in Journal of Racial and Ethnic Health Disparities
Verified
Journal Article
Closed access
PDF file
JRJosefina Romaguera
Josefina Romaguera
DCD. Caballero-Varona
D. Caballero-Varona
GTG. Tortolero-Luna
G. Tortolero-Luna
EME. Marrero
E. Marrero
ESE. Suárez
E. Suárez
AOA. P. Ortiz
A. P. Ortiz

7 January 1990 in Acta Obstetricia et Gynecologica Scandinavica
Verified
Journal Article
Closed access
PDF file
JRJosefina Romaguera
Josefina Romaguera
Carmen D ZorrillaCarmen D Zorrilla
Carmen D Zorrilla
AVAlberto de la Vega
Alberto de la Vega
RFRuth Fromm
Ruth Fromm
RWRobert C. Wallach
Robert C. Wallach
KAKarlis Adamsons
Karlis Adamsons
Since 1982 we have accelerated fetal maturation with intra‐amniotic thyr‐oxine (T4) in more than 140 patients. The purpose of this analysis was to determine the rate of change of the ratio of lecithin to sphingomyelin (LIS) after administration of T4 at different gestational ages, and to compare the responses to the first and the second administration of T4. Fifty‐nine cases in which administration of T4 was continued for 2 weeks or more, and in which at least 3 determinations of L/S had been performed, were identified. Gestational age of the fetus at the inititiation of treatment ranged from 26 to 31 weeks (mean 29.3 weeks). Thyroxine was administered weekly in 200 to 500 mcg doses.Administration of T4 prior to the 27th week did not change the L/S. From the 27th and 31st week of gestation, the slope of the L/S, after the initial dose of T4 increased from 0.331wk to 1.05/wk. In contrast the slope of the untreated patients changed little reaching a maximum of 0.22 at the 33 week. L/S>2 was observed in 80% of cases after 2 weeks of therapy, when it had been initiated after the 26th week.The response to the second dose was about twice that of the first in fetuses 5 30 weeks, but was similar to that seen after the initial dose in fetuses >30 weeks. Phosphatidylglycerol (PG) was detected in amniotic fluid in 51% of cases after 2 weeks of treatment, and in 6 instances as early as at the 30th week.Responsiveness of L/S to T4 treatment of the fetus is a function of gestational age and of prior exposure to T4.